Financials
- Market Capitalization 6.06 M
- Employee 4
- Founded 2017
- CEO David P Luci
- Website www.acurxpharma.com
- Headquarter Delaware, United States
- FIGI BBG01184DNJ4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4868 | ADXN Addex Therapeutics Ltd - American Depositary Shares | 5.06 USD | -9.64% | -12.76% | -12.76% | -36.91% | 6.23 M USD | ||
| 4869 | PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.58 USD | -3.33% | -3.33% | -26.58% | -43.14% | 6.23 M USD | ||
| 4878 | CURX Curanex Pharmaceuticals Inc - Common Stock | 0.21 USD | +10.53% | +5.00% | -27.59% | -94.47% | 5.96 M USD | ||
| 4881 | OABIW OmniAb, Inc. - Warrant | 0.0405 USD | 0.00% | -33.61% | -49.94% | -80.24% | 5.87 M USD |